Ariad Pharmaceuticals, Inc. Share Price
Equities
US04033A1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2017 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
2014 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Managers | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+4.58% | 11TCr | |
+11.70% | 11TCr | |
+0.76% | 2.23TCr | |
-11.58% | 2.21TCr | |
-7.56% | 1.87TCr | |
-38.36% | 1.76TCr | |
-10.50% | 1.69TCr | |
+4.74% | 1.38TCr | |
+36.89% | 1.25TCr |
- Stock Market
- Equities
- Stock